Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,010 public trials 1,222 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma

NCT03635983

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Local Institution - 0187 Tucson, Arizona, United States
  • Local Institution - 0014 La Jolla, California, United States
  • Local Institution - 0122 Stanford, California, United States
  • Local Institution - 0051 Aurora, Colorado, United States
View all 167 locations
View Trial Details
Completed

Nivolumab +/- Ipilimumab in Patients With Advanced, Refractory Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Tumors (NECs)

NCT03591731

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations
  • Centre Hospitalier du Pays d'Aix Aix-en-Provence, France
  • CHU d'Amiens-Picardie Amiens, France
  • CHU d'Angers Angers, France
  • Auxerre - CH Auxerre, France
View Trial Details
Completed

Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery

NCT00381641

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +37 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Decatur Memorial Hospital Decatur, Illinois, United States
  • NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States
  • Ingalls Memorial Hospital Harvey, Illinois, United States
View all 17 locations
View Trial Details
Completed

Nutrition in Gastroenteropancreatic Neuroendocrine Tumor

NCT04986085

Conditions
Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor, Neoplasms, +5 more
Locations
  • Hospital Universitario Virgen de la Arrixaca El Palmar, Murcia, Spain
  • Hospital Universitario Vall d´Hebron Barcelona, Spain
  • Hospital Universitario Reina Sofia Córdoba, Spain
  • Hospital Universitario de Cabueñes Gijón, Spain
View all 16 locations
View Trial Details
Completed

Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

NCT03522298

Conditions
Astrocytoma, Glioblastoma, Glioblastoma, Adult, +8 more
Locations
  • University of California Los Angeles - Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details

Related conditions